Cytosorbents (NASDAQ:CTSO) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Cytosorbents (NASDAQ:CTSO – Free Report) in a report published on Thursday. The brokerage issued a hold rating on the medical research company’s stock. Separately, D. Boral Capital restated a “buy” rating and issued a $10.00 price target on shares of Cytosorbents in a research report on Tuesday. Two research […]

Leave a Reply

Your email address will not be published.

Cytosorbents (NASDAQ:CTSO) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Cytosorbents (NASDAQ:CTSO – Free Report) in a report published on Thursday. The brokerage issued a hold rating on the medical research company’s stock. Separately, D. Boral Capital restated a “buy” rating and issued a $10.00 price target on shares of Cytosorbents in a research report on Tuesday. Two research […]

Leave a Reply

Your email address will not be published.

Cytosorbents (NASDAQ:CTSO) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Cytosorbents (NASDAQ:CTSO – Free Report) in a report published on Thursday. The brokerage issued a hold rating on the medical research company’s stock. Separately, D. Boral Capital restated a “buy” rating and issued a $10.00 price target on shares of Cytosorbents in a research report on Tuesday. Two research […]

Leave a Reply

Your email address will not be published.

Cytosorbents (NASDAQ:CTSO) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Cytosorbents (NASDAQ:CTSO – Free Report) in a report published on Thursday. The brokerage issued a hold rating on the medical research company’s stock. Separately, D. Boral Capital restated a “buy” rating and issued a $10.00 price target on shares of Cytosorbents in a research report on Tuesday. Two research […]

Leave a Reply

Your email address will not be published.

Previous post ‘The Friend’ a sweet dog tale — and more
Next post Piper Sandler Has Lowered Expectations for nCino (NASDAQ:NCNO) Stock Price